BCIQ Profiles

Company Profile Report

Prism’s peptide mimetic platform finds second discovery partner

Prism has closed a deal with its second large pharma partner, agreeing to collaborate with Boehringer to discover multiple compounds using its peptide mimetic platform.

Financial terms and

Read the full 278 word article

How to gain access

Continue reading with a
two-week free trial.